Posted in | News | Plastics and Polymers

iSmithers Rapra Releases Update on Polymers for Ocular Drug Delivery.

iSmithers Rapra Publishing has announced the release of Update on Polymers for Ocular Drug Delivery.

Update on Polymers for Ocular Drug Delivery

The eye is the most easily accessible site for topical administration of a medication. Drugs are commonly applied to the eye for localised action on the surface or in the interior of the eye. A major problem in ocular therapeutics is the attainment of an optimal drug concentration at the site of action. Poor bioavailability of drugs from ocular dosage forms is mainly due to the precorneal loss factors which include tear dynamics, non-productive absorption, transient residence time in the cul-de-sac, and the relative impermeability of the corneal epithelial membrane. Due to these physiological and anatomical constraints only a small fraction of the drug, effectively 1% or even less of the instilled dose is ocularly absorbed.

The effective dose of medication administered ophthalmically may be altered by increasing the retention time of medication in contact with the surface of the eye. To date, Pharmaceutical Technologists have tried to develop different novel formulations like gel, ocular inserts, collagen shields, implants, liposomes, nanoparticles, penetration enhancers and in-situ gelling systems, in order to increase the bioavailability and duration of the therapeutic action of ocular drugs and polymers plays an important role in all these approaches.

This book provides detailed information regarding all such polymers which have been used and shown to be excellent in improving the bioavailability of ocular drugs.

Update on Polymers for Ocular Drug Delivery is available from retailers, at www.polymer-books.com

Read a Sample Chapter and view the Table of Contents.

About Smithers Rapra:
Smithers Rapra is a wholly owned subsidiary of The Smithers Group and is recognised as a World leading rubber, plastic and composite consultancy. Smithers Rapra provides a comprehensive independent service covering, testing, analysis, processing and research for the polymer industry and industries using plastic, rubber and composites in any component, product or production process. www.rapra.net
About iSmithers:
iSmithers evolved from the information division of Smithers Rapra in 2008 after delivering over 30 years of knowledge transfer solutions. It serves a global academic and industrial market with polymer, chemical, pharmaceutical, ecotoxicology and life-science related knowledge and information products and events. These include a wide range of technology and market-based journals and books, national and international conferences, polymer technology training courses and electronic web and database products. www.ismithers.net

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Smithers Rapra Technology Ltd. (2019, February 09). iSmithers Rapra Releases Update on Polymers for Ocular Drug Delivery.. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=31508.

  • MLA

    Smithers Rapra Technology Ltd. "iSmithers Rapra Releases Update on Polymers for Ocular Drug Delivery.". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=31508>.

  • Chicago

    Smithers Rapra Technology Ltd. "iSmithers Rapra Releases Update on Polymers for Ocular Drug Delivery.". AZoM. https://www.azom.com/news.aspx?newsID=31508. (accessed November 21, 2024).

  • Harvard

    Smithers Rapra Technology Ltd. 2019. iSmithers Rapra Releases Update on Polymers for Ocular Drug Delivery.. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=31508.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.